129 related articles for article (PubMed ID: 11759635)
1. Summaries for patients. Outcomes of chronic infection with hepatitis B virus.
Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759635
[No Abstract] [Full Text] [Related]
2. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.
McMahon BJ; Holck P; Bulkow L; Snowball M
Ann Intern Med; 2001 Nov; 135(9):759-68. PubMed ID: 11694101
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiology of HBV related hepatocellular carcinoma in Japan].
Nishiguchi S; Tamori A; Kuroki T; Oka H; Tanaka T; Monna T
Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):673-9. PubMed ID: 12442466
[No Abstract] [Full Text] [Related]
4. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers.
McMahon BJ; Alberts SR; Wainwright RB; Bulkow L; Lanier AP
Arch Intern Med; 1990 May; 150(5):1051-4. PubMed ID: 2158773
[TBL] [Abstract][Full Text] [Related]
5. Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.
Bortolotti F; Guido M; Bartolacci S; Cadrobbi P; Crivellaro C; Noventa F; Morsica G; Moriondo M; Gatta A
Hepatology; 2006 Mar; 43(3):556-62. PubMed ID: 16496323
[TBL] [Abstract][Full Text] [Related]
6. Natural course of persistent hepatitis B virus infection in hepatitis B e antigen-positive and hepatitis B e antigen-negative cohorts in Japan based on the Markov model.
Yamasaki K; Tanaka J; Kurisu A; Akita T; Ohisa M; Sakamune K; Ko K; Sugiyama A; Yasaka T; Shirahama S
J Med Virol; 2018 Dec; 90(12):1800-1813. PubMed ID: 29995323
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B e antigen and the risk of hepatocellular carcinoma.
Yang HI; Lu SN; Liaw YF; You SL; Sun CA; Wang LY; Hsiao CK; Chen PJ; Chen DS; Chen CJ;
N Engl J Med; 2002 Jul; 347(3):168-74. PubMed ID: 12124405
[TBL] [Abstract][Full Text] [Related]
8. [Long-term history of chronic hepatitis B virus infection in children].
Fujisawa T; Inui A; Sogo T; Komatsu H
Nihon Rinsho; 2004 Aug; 62 Suppl 8():303-8. PubMed ID: 15453335
[No Abstract] [Full Text] [Related]
9. Hepatitis B e Antigen--the dangerous endgame of hepatitis B.
Liang TJ; Ghany M
N Engl J Med; 2002 Jul; 347(3):208-10. PubMed ID: 12124411
[No Abstract] [Full Text] [Related]
10. Hepatitis B core-related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma.
To WP; Mak LY; Wong DK; Fung J; Liu F; Seto WK; Lai CL; Yuen MF
J Viral Hepat; 2019 Dec; 26(12):1473-1480. PubMed ID: 31418973
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B e Antigen and the Risk of Hepatocellular Carcinoma.
Geier A; Gartung C; Dietrich CG
N Engl J Med; 2002 Nov; 347(21):1721-2; author reply 1721-2. PubMed ID: 12444194
[No Abstract] [Full Text] [Related]
12. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
13. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
14. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
Chu CM
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
[TBL] [Abstract][Full Text] [Related]
15. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F.
Livingston SE; Simonetti JP; Bulkow LR; Homan CE; Snowball MM; Cagle HH; Negus SE; McMahon BJ
Gastroenterology; 2007 Nov; 133(5):1452-7. PubMed ID: 17920063
[TBL] [Abstract][Full Text] [Related]
16. Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus.
Simonetti J; Bulkow L; McMahon BJ; Homan C; Snowball M; Negus S; Williams J; Livingston SE
Hepatology; 2010 May; 51(5):1531-7. PubMed ID: 20087968
[TBL] [Abstract][Full Text] [Related]
17. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
[TBL] [Abstract][Full Text] [Related]
19. High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: a long-term follow-up study.
Moucari R; Korevaar A; Lada O; Martinot-Peignoux M; Boyer N; Mackiewicz V; Dauvergne A; Cardoso AC; Asselah T; Nicolas-Chanoine MH; Vidaud M; Valla D; Bedossa P; Marcellin P
J Hepatol; 2009 Jun; 50(6):1084-92. PubMed ID: 19376603
[TBL] [Abstract][Full Text] [Related]
20. Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.
Harpaz R; McMahon BJ; Margolis HS; Shapiro CN; Havron D; Carpenter G; Bulkow LR; Wainwright RB
J Infect Dis; 2000 Feb; 181(2):413-8. PubMed ID: 10669320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
